A portfolio revenue forecast based on simulations is used, explaining how simulations can elevate portfolio analysis.
How will trial delays impact the ability to deliver the R&D portfolio. Looking at delay impacts on value, launches and sales.
Starting with describing a baseline portfolio, we then show a couple of examples on how to assess improvement strategies.
Evaluating Fast Track Opportunities
Showing an example of how to use quantitative analytics to evaluate potential fast track opportunities in early stage projects.
NDA Submission Strategy
Looking at the launch strategy for a compound targeted for multiple indications, considering parallel or sequential filing.
Clinical Trial Recruitment Impact
Exploring the downstream delay impacts on trial duration, launch timing, competitive positioning within the marketplace and NPV.